P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION.
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000968944.09972.17 |
_version_ | 1797281658358988800 |
---|---|
author | Mahesh Swaminathan Rashmi Kanagal-Shamanna Farhad Ravandi Tapan Kadia Courtney Dinardo Naval Daver Naveen Pemmaraju Elias Jabbour Sherry Pierce John Matthew Villareal Gautam Borthakur |
author_facet | Mahesh Swaminathan Rashmi Kanagal-Shamanna Farhad Ravandi Tapan Kadia Courtney Dinardo Naval Daver Naveen Pemmaraju Elias Jabbour Sherry Pierce John Matthew Villareal Gautam Borthakur |
author_sort | Mahesh Swaminathan |
collection | DOAJ |
first_indexed | 2024-03-07T17:00:36Z |
format | Article |
id | doaj.art-0b85103da5e04c68995bda71740b6e62 |
institution | Directory Open Access Journal |
issn | 2572-9241 |
language | English |
last_indexed | 2024-03-07T17:00:36Z |
publishDate | 2023-08-01 |
publisher | Wiley |
record_format | Article |
series | HemaSphere |
spelling | doaj.art-0b85103da5e04c68995bda71740b6e622024-03-03T03:24:19ZengWileyHemaSphere2572-92412023-08-017e099721710.1097/01.HS9.0000968944.09972.17202308003-00410P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION.Mahesh Swaminathan0Rashmi Kanagal-Shamanna1Farhad Ravandi2Tapan Kadia3Courtney Dinardo4Naval Daver5Naveen Pemmaraju6Elias Jabbour7Sherry Pierce8John Matthew Villareal9Gautam Borthakur101 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States1 University of Texas MD Anderson Cancer Center, Leukemia, Houston, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000968944.09972.17 |
spellingShingle | Mahesh Swaminathan Rashmi Kanagal-Shamanna Farhad Ravandi Tapan Kadia Courtney Dinardo Naval Daver Naveen Pemmaraju Elias Jabbour Sherry Pierce John Matthew Villareal Gautam Borthakur P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. HemaSphere |
title | P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. |
title_full | P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. |
title_fullStr | P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. |
title_full_unstemmed | P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. |
title_short | P509: THE IMPACT OF THE NUMBER OF RAS MUTATIONS IN THE OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED FRONTLINE AT A SINGLE INSTITUTION. |
title_sort | p509 the impact of the number of ras mutations in the outcomes of patients with acute myeloid leukemia treated frontline at a single institution |
url | http://journals.lww.com/10.1097/01.HS9.0000968944.09972.17 |
work_keys_str_mv | AT maheshswaminathan p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT rashmikanagalshamanna p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT farhadravandi p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT tapankadia p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT courtneydinardo p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT navaldaver p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT naveenpemmaraju p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT eliasjabbour p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT sherrypierce p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT johnmatthewvillareal p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution AT gautamborthakur p509theimpactofthenumberofrasmutationsintheoutcomesofpatientswithacutemyeloidleukemiatreatedfrontlineatasingleinstitution |